Satoshi Kawaguchi is an Assistant Professor at the department of emergency medicine of Asahikawa Medical University (AMU). He graduated from AMU in 2010 and got a PhD in 2020. He is working as a clinical doctor and a researcher at AMU.He has a broad background in cardiovascular surgery and research, with specific training and expertise in clinical and research areas in the US. His clinical specialty is cardiology and emergency medicine and he has been engaged in treatments for heart failure. βAR blockers (βARs) are one of the best therapies for heart failure patients and he became interested in the beneficial mechanisms of βARs in heart failure. His research interest is βAR signaling and its beneficial effects for various types of heart failure.
Satoshi Kawaguchi is an Assistant Professor at the department of emergency medicine of Asahikawa Medical University (AMU). He graduated from AMU in 2010 and got a PhD in 2020. He is working as a clinical doctor and a researcher at AMU.He has a broad background in cardiovascular surgery and research, with specific training and expertise in clinical and research areas in the US. His clinical specialty is cardiology and emergency medicine and he has been engaged in treatments for heart failure. βAR blockers (βARs) are one of the best therapies for heart failure patients and he became interested in the beneficial mechanisms of βARs in heart failure. His research interest is βAR signaling and its beneficial effects for various types of heart failure.